Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Pigazzani

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Antioxidants (Basel, Switzerland)|August 26, 2022
The Prognostic Value of Derivatives-Reactive Oxygen Metabolites (d-ROMs) for Cardiovascular Disease Events and Mortality: A ReviewFilippo Pigazzani, Davide Gorni, Kenneth A Dyar, et al.
BMC Medicine|May 20, 2026
Design considerations for hypertension chronotherapy trials: insights from experience and modellingOlivia Walch, Amy Rogers, Yitong P Huang, et al.
Journal of Hypertension|February 26, 2015
Multiparametric carotid and cardiac ultrasound compared with clinical risk scores for the prediction of angiographic coronary artery disease: a multicenter prospective studyAntonella Moreo, Nicola Gaibazzi, Pompilio Faggiano, et al.
Eclinicalmedicine|May 22, 2024
Effect of timed dosing of usual antihypertensives according to patient chronotype on cardiovascular outcomes: the Chronotype sub-study cohort of the Treatment in Morning versus Evening (TIME) studyFilippo Pigazzani, Kenneth A Dyar, Steve V Morant, et al.
Journal of the American College of Cardiology|March 16, 2018
Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes: The PHARMCLO TrialFrancesca Maria Notarangelo, Giuseppe Maglietta, Paola Bevilacqua, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 11, 2015
Rapid and portable, lab-on-chip, point-of-care genotyping for evaluating clopidogrel metabolismNicola Marziliano, Maria Francesca Notarangelo, Marco Cereda, et al.
Lancet (London, England)|October 14, 2022
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trialIsla S Mackenzie, Amy Rogers, Neil R Poulter, et al.
Journal of Affective Disorders|July 9, 2026
Meal Timing Jetlag is associated with anxiety, depressive and insomnia symptoms in a French-speaking online cohort: A cross-sectional analysis of ALIMENTAL 2Guillaume Fond, Julien Coelho, Brendon Stubbs, et al.
Scientific Reports|December 22, 2019
Sighting acute myocardial infarction through platelet gene expressionGiuliana Gobbi, Cecilia Carubbi, Guidantonio Malagoli Tagliazucchi, et al.
Health Technology Assessment (Winchester, England)|March 29, 2024
Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluationIsla S Mackenzie, Christopher J Hawkey, Ian Ford, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Antioxidants (Basel, Switzerland)|August 26, 2022
The Prognostic Value of Derivatives-Reactive Oxygen Metabolites (d-ROMs) for Cardiovascular Disease Events and Mortality: A ReviewFilippo Pigazzani, Davide Gorni, Kenneth A Dyar, et al.
BMC Medicine|May 20, 2026
Design considerations for hypertension chronotherapy trials: insights from experience and modellingOlivia Walch, Amy Rogers, Yitong P Huang, et al.
Journal of Hypertension|February 26, 2015
Multiparametric carotid and cardiac ultrasound compared with clinical risk scores for the prediction of angiographic coronary artery disease: a multicenter prospective studyAntonella Moreo, Nicola Gaibazzi, Pompilio Faggiano, et al.
Eclinicalmedicine|May 22, 2024
Effect of timed dosing of usual antihypertensives according to patient chronotype on cardiovascular outcomes: the Chronotype sub-study cohort of the Treatment in Morning versus Evening (TIME) studyFilippo Pigazzani, Kenneth A Dyar, Steve V Morant, et al.
Journal of the American College of Cardiology|March 16, 2018
Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes: The PHARMCLO TrialFrancesca Maria Notarangelo, Giuseppe Maglietta, Paola Bevilacqua, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 11, 2015
Rapid and portable, lab-on-chip, point-of-care genotyping for evaluating clopidogrel metabolismNicola Marziliano, Maria Francesca Notarangelo, Marco Cereda, et al.
Lancet (London, England)|October 14, 2022
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trialIsla S Mackenzie, Amy Rogers, Neil R Poulter, et al.
Journal of Affective Disorders|July 9, 2026
Meal Timing Jetlag is associated with anxiety, depressive and insomnia symptoms in a French-speaking online cohort: A cross-sectional analysis of ALIMENTAL 2Guillaume Fond, Julien Coelho, Brendon Stubbs, et al.
Scientific Reports|December 22, 2019
Sighting acute myocardial infarction through platelet gene expressionGiuliana Gobbi, Cecilia Carubbi, Guidantonio Malagoli Tagliazucchi, et al.
Health Technology Assessment (Winchester, England)|March 29, 2024
Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluationIsla S Mackenzie, Christopher J Hawkey, Ian Ford, et al.
Pageof 3